Horie Shigeo｜Juntendo University

Department of Urology

1985	M.D. and finished his residency at The University of Tokyo
1988	Research and Clinical Fellowship at the UT Southwestern Medical Center at Dallas, USA
1991	Member of the faculties, Department of Urology, The University of Tokyo
1995	Department of Urology, National Cancer Center
2002	Associate Professor, Department of Urology, Kyorin University
2003	Professor, Department of Urology, Teikyo University
2012	Professor, Department of Urology, Juntendo University Faculty of Medicine

Muto S, Kamiyama Y, Ide H, Okada H, Saito K, Nishio K, Tokiwa S, Kaminaga T, Furui S, Horie S: Real-time MRI of Orthotopic ileal neobladder voiding: preliminary findings. European Urology, 2008; 53: 363-369.
Muto S, Yoshii T, Saito K, Kamiyama Y, Ide H, Horie S: Focal therapy with High-Intensity Focused Ultrasound in the treatment of localized prostate cancer. Japanese Journal of Clinical Oncology, 2008 Mar; 38 (3):192-9.
Yasuda M, Ide H, Furuya K, Yoshii T, Nishio K, Saito K, Isotani S, Kamiyama Y, Muto S, Horie S. Salivary 8-OHdG: a useful biomarker for predicting severe ED and hypogonadism. Journal of Sexual Medicine, 2008; 5: 1482-91.
Ide H, Tokiwa S, Sakamaki K, Nishio K, Isotani S, Muto S, Hama T, Masuda H, Horie S. Combined inhibitory effects of soy isoflavones and curcumin on the production of Prostate-specific antigen; a randomized placebo-controlled clinical study. Prostate, 2010 Jul 1; 70 (10):1127-33.
Ide H, Lu Y, Yu J, China T, Kumamoto T, Koseki T, Yamaguchi R, Muto S, Horie S. Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines. Prostate, 2012 Jan 30. [Epub ahead of print]
More